R. Hasselback
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
-
- Neutropenia and Cancer Infections
Papers in
- Hematology 13
- Acute Myeloid Leukemia Research 5
- Hematopoietic Stem Cell Transplantation 3
- Hemostasis and retained surgical items 2
- Chronic Myeloid Leukemia Treatments 2
-
- Acute Lymphoblastic Leukemia research 5
- Co-authors
- Daniel E. Bergsagel (5 shared papers)D. H. Cowan (5 shared papers)Peter Fredrik Hjort (2 shared papers)Gary L. Robertson (2 shared papers)J. E. Curtis (3 shared papers)Ronald Feld (1 shared paper)Anne Matlow (1 shared paper)Eliane Haron (1 shared paper)
In The Last Decade
R. Hasselback
20 papers receiving 458 citations
Peers
Comparison fields: 5 of 72
- Hematology 205
- Oncology 185
- Genetics 67
- Infectious Diseases 86
- Pathology and Forensic Medicine 80
Countries citing papers authored by R. Hasselback
This map shows the geographic impact of R. Hasselback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Hasselback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Hasselback more than expected).
Fields of papers citing papers by R. Hasselback
This network shows the impact of papers produced by R. Hasselback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Hasselback. The network helps show where R. Hasselback may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Hasselback, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1987 | 103 | |
| 2 | Plasma cell myeloma: response of melphalan-resistant patients to high-dose intermittent cyclophosphamide. | 1972 | 65 |
| 3 | Results of treating Hodgkin's disease without a policy of laparotomy staging. | 1982 | 58 |
| 4 | Effect of cyclophosphamide on advanced lung cancer and the hematological toxicity of large, intermittent intravenous doses. | 1968 | 51 |
| 5 | Acute leukemia in adults: assessment of remission induction with combination chemotherapy by clinical and cell-culture criteria. | 1975 | 39 |
| 6 | 1984 | 37 | |
| 7 | Congenital hypofibrinogenemia in five members of a family. | 1963 | 29 |
| 8 | 1961 | 28 | |
| 9 | 1960 | 25 | |
| 10 | 1963 | 25 | |
| 11 | 1978 | 21 | |
| 12 | The influence of morphology on prognosis in acute leukemia. | 1967 | 18 |
| 13 | Leukocyte transfusions for the prophylaxis and treatment of infections associated with granulocytopenia. | 1977 | 12 |
| 14 | Remission maintenance of acute nonlymphoblastic leukemia with BCNU (NSC-409962) and cyclophosphamide (NSC-26271). | 1976 | 10 |
| 15 | Treatment of acute myeloblastic leukemia in adults: remission induction with a combination of cyclophosphamide, cytarabine and vincristine. | 1972 | 9 |
| 16 | A critical review of the evidence for a continous hemostasis in vivo. | 1961 | 7 |
| 17 | 1971 | 6 | |
| 18 | Preliminary Survey of 4-Amino-5-Imidazolecarboxamide Excretion in Leukemia and Other Illnesses. | 1961 | 5 |
| 19 | Bone marrow transplantation in patients with acute leukaemia. | 1972 | 4 |
| 20 | Blood banking. I. Abnormal antibodies and their detection. | 1961 | 2 |
About R. Hasselback
R. Hasselback is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 20 papers that have together received 554 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers), Hematopoietic Stem Cell Transplantation (3 papers), Neutropenia and Cancer Infections (3 papers), Hemostasis and retained surgical items (2 papers), Lymphoma Diagnosis and Treatment (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Blood properties and coagulation (2 papers). The work is most often cited by research in Hematology (205 citations), Oncology (185 citations), Genetics (67 citations), Infectious Diseases (86 citations) and Pathology and Forensic Medicine (80 citations). R. Hasselback has collaborated with scholars based in Canada and Norway. Frequent co-authors include Daniel E. Bergsagel, D. H. Cowan, Peter Fredrik Hjort, Gary L. Robertson, J. E. Curtis, Ronald Feld, Anne Matlow, Eliane Haron, Peter G. Tuffnell and Bruce Patterson. Their work appears in journals such as The American Journal of Medicine, Journal of Clinical Oncology, Journal of Applied Physiology, Science and Thrombosis and Haemostasis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.